Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros








Base de dados
Tipo de estudo
Intervalo de ano de publicação
1.
Artigo em Russo | MEDLINE | ID: mdl-19462521

RESUMO

Literature data about mechanisms of interaction between viruses and bacteria in circumstances of associative symbiosis are summarized. Interactions of influenza viruses, adenoviruses, Coxsackie viruses with different taxons of pathogenic and opportunistic bacteria are showed. Influence of these interactions on pathogenicity factors of viruses and bacteria is multidirectional (induction, suppression) which could determine the course of infectious process.


Assuntos
Bactérias/patogenicidade , Infecções Bacterianas/virologia , Simbiose , Viroses/microbiologia , Vírus/patogenicidade , Animais , Infecções Bacterianas/complicações , Humanos , Viroses/complicações
2.
Artigo em Russo | MEDLINE | ID: mdl-12966884

RESUMO

In a number of in vitro experiments the effect of oxytocin on the antilysozyme and anticomplemental activity of Propiobacterium propionicum, Bacteroides fragilis, Prevotella melaninogenica and Peptostreprtococcus anaerobius, isolated from patients with acute pyoinflammatory pleuropulmonary diseases, was studied. Antibiotic resistance dynamics of the infective agents under study to lincomycin, clindamycin, thienam, vancomycin was also detected. The inhibiting activity of oxytocin on the persistence properties of B. fragilis, P. melanogenica and P. anaerobius was noted. Under the influence of the preparations used changes in the sensitivity of the strains to a number of antibiotics of the lincosamide, carbapenem and glycopeptide groups were found to occur. The data thus obtained were indicative of the possible mechanisms of action of oxytocin in the treatment of acute pyoinflammatory pleuropulmonary diseases of anaerobic nonclostridial etiology.


Assuntos
Antibacterianos/farmacologia , Bactérias Anaeróbias/efeitos dos fármacos , Ocitocina/farmacologia , Bactérias Anaeróbias/isolamento & purificação , Bactérias Anaeróbias/metabolismo , Bacteroides/efeitos dos fármacos , Bacteroides/isolamento & purificação , Bacteroides/metabolismo , Proteínas Inativadoras do Complemento/metabolismo , Resistência Microbiana a Medicamentos , Empiema Pleural/microbiologia , Inibidores Enzimáticos/metabolismo , Humanos , Testes de Sensibilidade Microbiana , Muramidase/antagonistas & inibidores , Muramidase/metabolismo , Peptostreptococcus/efeitos dos fármacos , Peptostreptococcus/isolamento & purificação , Peptostreptococcus/metabolismo , Pneumotórax/microbiologia , Prevotella/efeitos dos fármacos , Prevotella/isolamento & purificação , Prevotella/metabolismo
3.
Artigo em Russo | MEDLINE | ID: mdl-12966885

RESUMO

The effect of the synthetic immunomodulator polyoxydonium (PO) on some biological properties of pathogenic bacteria (Shigella flexneri, Salmonella enteritidis), opportunistic bacteria (Klebsiella pneumoniae, Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Bacteroides fragilis, Peptostreptococcus anaerobius, Prevotella melaninogenica, Propionibacterium propionicum, Clostridium difficile) and fungi (Candida albicans), isolated during enteric infections, enteric dysbiosis, pyoinflammatory diseases, was evaluated in a number of in vitro experiments. The study revealed that the recommended therapeutic concentration of PO decreased antilysozyme activity (ALA) and the anticomplement activity in Klebsiella, Shigella, Propionibacterium, Clostridium, bacteroids, fungi of the genus Candida, but increased ALA in nonhemolytic Escherichia. Under the action of PO an increased sensitivity of the microorganisms under study to definite antibiotics of the lincosamide, fluoroquinolon, carbapenem and cephalosporin groups was noted. The data obtained in this study reveal one of the possible mechanisms of the corrective action of PO on the microbiocenosis of the intestine in dysbiosis, enteric infections and pyoinflammatory diseases.


Assuntos
Adjuvantes Imunológicos/farmacologia , Bactérias Aeróbias/efeitos dos fármacos , Bactérias Anaeróbias/efeitos dos fármacos , Fungos/efeitos dos fármacos , Antibacterianos/farmacologia , Bactérias Aeróbias/crescimento & desenvolvimento , Bactérias Aeróbias/metabolismo , Bactérias Anaeróbias/crescimento & desenvolvimento , Bactérias Anaeróbias/metabolismo , Proteínas Inativadoras do Complemento/metabolismo , Enterite/microbiologia , Inibidores Enzimáticos/metabolismo , Fungos/metabolismo , Humanos , Testes de Sensibilidade Microbiana , Muramidase/antagonistas & inibidores , Muramidase/metabolismo , Compostos Orgânicos , Infecções Respiratórias/microbiologia
4.
Artigo em Russo | MEDLINE | ID: mdl-12966888

RESUMO

The presence of the persistence factors (anti-lysozyme and anti-complement activity) in the vegetative forms of C. difficile was experimentally proved. The effect of different medicines (vitamins B1, B6 and C, prebiotic inulin, probiotics Bifidumbacterin and Enterol) on the persistence factors of C. difficile and microbial resistance to vancomycin, thienam, lincomycin, clindamycin was evaluated. The anti-lysozyme and anti-complement activity of C. difficile was found to decrease under the influence of vitamins B1, B6, C, inulin, exometabolites of bifidobacteria. Under the impact of the preparations used in this study changes in the sensitivity of C. difficile to antibiotics of the lincoamide, carbapenem, glycopeptide groups were found to occur. The data obtained reveal one of the possible mechanisms of the corrective action of the medicines under study on the intestinal microbiocenosis in patients with antibiotic-associated colitis.


Assuntos
Clostridioides difficile/efeitos dos fármacos , Antibacterianos/farmacologia , Cilastatina/farmacologia , Combinação Imipenem e Cilastatina , Clostridioides difficile/metabolismo , Clostridioides difficile/fisiologia , Proteínas Inativadoras do Complemento/análise , Proteínas Inativadoras do Complemento/metabolismo , Combinação de Medicamentos , Farmacorresistência Bacteriana/efeitos dos fármacos , Enterocolite Pseudomembranosa/microbiologia , Inibidores Enzimáticos/análise , Inibidores Enzimáticos/metabolismo , Humanos , Imipenem/farmacologia , Inulina/farmacologia , Testes de Sensibilidade Microbiana , Muramidase/antagonistas & inibidores , Probióticos/farmacologia , Vitaminas/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA